The effect of morphine and fentanyl use in patients with corona

Phase 3

• Conditions: Coronavirus infection, unspecified; SARS-COV-2.; B34.2

• Registration Number: IRCT20150725023332N4
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Liver enzymes <2 times the normal range
No intubation
Evidence of new coronavirus (COVID-19) (clinical or paraclinical)

Exclusion Criteria

Sensitivity to opium
Addiction to opium
Addiction to alcohol

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
C-Reactive Protein (CRP). Timepoint: Before applying the intervention, then 24 hours and 48 hours after the intervention. Method of measurement: Biochemical tests (spectrophotometric method).;Immunoglobulin G (IgG). Timepoint: Before applying the intervention, then 24 hours and 48 hours after the intervention. Method of measurement: Immunological tests (competitive ELISA method).